B
BeiGene
A global oncology company developing and commercializing innovative cancer treatments.
About
BeOne Medicines is a global oncology company dedicated to discovering, developing, and commercializing transformative cancer medicines. They focus on advancing a broad pipeline through rigorous science, including pioneering protein degradation with CDACs and antibody drug conjugates, to serve patients worldwide. BeOne Medicines aims to build the world's leading oncology company, driven by scientific excellence and speed to reach more patients.
Tags
Company Timeline
Funding rounds, employee growth, revenue, and exits over the same period. News mentions shown as markers.
No timeline data for this period
Score Breakdown
64Traction
40Team
60Visibility
2Profile
65Community
15Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does BeiGene do?
BeOne Medicines is a global oncology company dedicated to discovering, developing, and commercializing transformative cancer medicines. They focus on advancing a broad pipeline through rigorous science, including pioneering protein degradation with CDACs and antibody drug conjugates, to serve patients worldwide. BeOne Medicines aims to build the world's leading oncology company, driven by scientific excellence and speed to reach more patients.
How much funding has BeiGene raised?
BeiGene has raised a total of $358M in funding. The most recent round on record is Secondary Offering.
Where is BeiGene headquartered?
BeiGene is headquartered in Cambridge, Massachusetts, U.S..
When was BeiGene founded?
BeiGene was founded in 2010.
What industry does BeiGene operate in?
BeiGene operates in Biotech, MedTech, HealthTech, Genomics, Drug Discovery, Clinical Trials.
What is BeiGene's current status?
BeiGene's current operating status is: Public.